|
1.
|
Thun MJ, Oliver DeLancey J, Center MM,
Jemal A and Ward EM: The global burden of cancer: priorities for
prevention. Carcinogenesis. 31:100–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Lee MY and Shen MR: Epithelial-mesenchymal
transition in cervical carcinoma. Am J Transl Res. 4:1–13.
2012.PubMed/NCBI
|
|
3.
|
Castellsague X: Natural history and
epidemiology of HPV infection and cervical cancer. Gynecol Oncol.
110:S4–S7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Burd EM: Human papillomavirus and cervical
cancer. Clin Microbiol Rev. 16:1–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
zur Hausen H: Papillomaviruses and cancer:
from basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002.PubMed/NCBI
|
|
6.
|
Au WW, Abdou-Salama S, Sierra-Torres CH
and Al-Hendy A: Environmental risk factors for prevention and
molecular intervention of cervical cancer. Int J Hyg Environ
Health. 210:671–678. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Wei LH, Kuo ML, Chen CA, Cheng WF, Cheng
SP, Hsieh FJ and Hsieh CY: Interleukin-6 in cervical cancer: the
relationship with vascular endothelial growth factor. Gynecol
Oncol. 82:49–56. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Wei LH, Kuo ML, Chen CA, Chou CH, Cheng
WF, Chang MC, Su JL and Hsieh CY: The anti-apoptotic role of
interleukin-6 in human cervical cancer is mediated by up-regulation
of Mcl-1 through a PI3-K/Akt pathway. Oncogene. 20:5799–5809. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Rose-John S: IL-6 trans-signaling via the
soluble IL-6 receptor: importance for the pro-inflammatory
activities of IL-6. Int J Biol Sci. 8:1237–1247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Braunstein J, Brutsaert S, Olson R and
Schindler C: Stats dimerize in the absence of phosphorylation. J
Biol Chem. 278:34133–34140. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Shukla S, Shishodia G, Mahata S, et al:
Aberrant expression and constitutive activation of Stat3 in
cervical carcinogenesis: implications in high-risk human
papillomavirus infection. Mol Cancer. 9:2822010. View Article : Google Scholar
|
|
12.
|
Chen CL, Hsieh FC, Lieblein JC, et al:
Stat3 activation in human endometrial and cervical cancers. Br J
Cancer. 96:591–599. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Aggarwal BB, Kunnumakkara AB, Harikumar
KB, et al: Signal transducer and activator of transcription-3,
inflammation, and cancer: how intimate is the relationship? Ann N Y
Acad Sci. 1171:59–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: new insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Trimboli AJ, Fukino K, Bruin A, et al:
Direct evidence for epithelial-mesenchymal transitions in breast
cancer. Cancer Res. 68:937–945. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Vergara D, Merlot B, Lucot JP, Collinet P,
Vinatier D, Fournier I and Salzet M: Epithelial-mesenchymal
transition in ovarian cancer. Cancer Lett. 291:59–66. 2009.
View Article : Google Scholar
|
|
17.
|
Brabletz T, Hlubek F, Spaderna S,
Schmalhofer O, Hiendlmeyer E, Jung A and Kirchner T: Invasion and
metastasis in colorectal cancer: epithelial-mesenchymal transition,
mesenchymal-epithelial transition, stem cells and beta-catenin.
Cells Tissues Organs. 179:56–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Usami Y, Satake S, Nakayama F, et al:
Snail-associated epithelial-mesenchymal transition promotes
oesophageal squamous cell carcinoma motility and progression. J
Pathol. 215:330–339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lee MY, Chou CY, Tang MJ and Shen MR:
Epithelial-mesenchymal transition in cervical cancer: correlation
with tumor progression, epidermal growth factor receptor
overexpression, and snail up-regulation. Clin Cancer Res.
14:4743–4750. 2008. View Article : Google Scholar
|
|
20.
|
Cervantes-Arias A, Pang LY and Argyle DJ:
Epithelial-mesenchymal transition as a fundamental mechanism
underlying the cancer phenotype. Vet Comp Oncol. 11:169–184. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Chen H, Paradies NE, Fedor-Chaiken M and
Brackenbury R: E-cadherin mediates adhesion and suppresses cell
motility via distinct mechanisms. J Cell Sci. 110:345–356.
1997.PubMed/NCBI
|
|
22.
|
McInroy L and Määttä A: Down-regulation of
vimentin expression inhibits carcinoma cell migration and adhesion.
Biochem Biophys Res Commun. 360:109–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Vuoriluoto K, Haugen H, Kiviluoto S, et
al: Vimentin regulates EMT induction by Slug and oncogenic H-Ras
and migration by governing Axl expression in breast cancer.
Oncogene. 30:1436–1448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Karantza V: Keratins in health and cancer:
more than mere epithelial cell markers. Oncogene. 30:127–138. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Di Como CJ, Urist MJ, Babayan I, Drobnjak
M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A and Cordon-Cardo
C: p63 expression profiles in human normal and tumor tissues. Clin
Cancer Res. 8:494–501. 2002.PubMed/NCBI
|
|
26.
|
Lin DL, Whitney MC, Yao Z and Keller ET:
Interleukin-6 induces androgen responsiveness in prostate cancer
cells through up-regulation of androgen receptor expression. Clin
Cancer Res. 7:1773–17781. 2001.PubMed/NCBI
|
|
27.
|
Xiao D and He J: Epithelial mesenchymal
transition and lung cancer. J Thorac Dis. 2:154–159.
2010.PubMed/NCBI
|
|
28.
|
Castrilli G, Tatone D, Diodoro MG, Rosini
S, Piantelli M and Musiani P: Interleukin 1alpha and interleukin 6
promote the in vitro growth of both normal and neoplastic human
cervical epithelial cells. Br J Cancer. 75:855–859. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Tjiong MY, van der Vange N, ten Kate FJ,
Tjong-A-Hung SP, ter Schegget J, Burger MP and Out TA: Increased
IL-6 and IL-8 levels in cervicovaginal secretions of patients with
cervical cancer. Gynecol Oncol. 73:285–291. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Cheng Y, Zhou Y, Jiang W, et al:
Significance of E-cadherin, β-catenin, and vimentin expression as
postoperative prognosis indicators in cervical squamous cell
carcinoma. Human Pathol. 43:1213–1220. 2012.
|
|
31.
|
Scanlon CS, Van Tubergen EA, Inglehart RC
and D’Silva NJ: Biomarkers of epithelial-mesenchymal transition in
squamous cell carcinoma. J Dent Res. 92:114–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Sullivan NJ, Sasser AK, Axel AE, Vesuna F,
Raman V, Ramirez N, Oberyszyn TM and Hall BM: Interleukin-6 induces
an epithelial-mesenchymal transition phenotype in human breast
cancer cells. Oncogene. 28:2940–2947. 2009. View Article : Google Scholar
|
|
33.
|
Bolós V, Peinado H, Pérez-Moreno MA, Fraga
MF, Esteller M and Cano A: The transcription factor Slug represses
E-cadherin expression and induces epithelial to mesenchymal
transitions: a comparison with Snail and E47 repressors. J Cell
Sci. 116:499–511. 2003.PubMed/NCBI
|
